Clinical Trial Update: Study to Evaluate Organic Anion Transporting Polypeptide (OATP) Transporter-Mediated Drug-Drug Interactions Between Filgotinib and Statins as Probe Drugs in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 study evaluating potential OATP-mediated drug-drug interactions between filgotinib and statins in healthy participants; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Filgotinib (filgotinib)
• Statins

Snippet

Sponsor: Gilead Sciences | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED | Results posted: 2022-01-19